I call the meeting to order.
Before we begin, I would just like to make a few comments for the benefit of our new witnesses for this panel. Please wait until I recognize you by name before speaking. For those participating by video conference, click on the microphone icon to activate your mic, and please mute yourself when you are not speaking. For those on Zoom, at the bottom of your screen, you can select the appropriate channel for interpretation: floor, English or French. For those in the room, you can use the earpiece and select the desired channel. I remind you that all comments should be addressed through the chair.
With that, I would like to welcome our three witnesses for this second panel.
Participating by video conference, we have Dr. Rita Dhami, adjunct clinical assistant professor at the school of pharmacy at the University of Waterloo. From Fedora Pharmaceuticals Inc. we have Dr. Sameeh Salama, chief science officer and chair, Canadian Antimicrobial Innovation Coalition. Our third witness is also joining by video conference. From Infection Prevention and Control Canada, we have Dr. Gregory Rose, infectious diseases and infection control consultant.
Welcome. Thanks a lot for appearing before the committee today.
You will have five minutes for your opening remarks, and then we will go into rounds of questioning.
We will begin with Dr. Dhami.
Please go ahead.